Gloria Matthews presented Ankasa Regenerative Technologies at LSI USA ‘24 Emerging Medtech Summit. Ankasa is developing ART352-L as a novel regenerative medicine. ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries. Learn More: https://ankasaregenerativetherapeutics.com/ Our Next Event → LSI Europe ‘24 in Portugal on September 16th - 20th, 2024 Join us today → https://www.lifesciencemarketresearch.com/medtech-summit-europe-2024 Follow us on social! LinkedIn: https://www.linkedin.com/company/life-science-intelligence/ Twitter: https://twitter.com/lsintelligence Instagram: https://www.instagram.com/lifescienceintelligence/ Facebook: https://www.facebook.com/LifeScienceIntelligence/ Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw